Your browser doesn't support javascript.
loading
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
Wong, Hui-Lee; Hu, Mao; Zhou, Cindy Ke; Lloyd, Patricia C; Amend, Kandace L; Beachler, Daniel C; Secora, Alex; McMahill-Walraven, Cheryl N; Lu, Yun; Wu, Yue; Ogilvie, Rachel P; Reich, Christian; Djibo, Djeneba Audrey; Wan, Zhiruo; Seeger, John D; Akhtar, Sandia; Jiao, Yixin; Chillarige, Yoganand; Do, Rose; Hornberger, John; Obidi, Joyce; Forshee, Richard; Shoaibi, Azadeh; Anderson, Steven A.
Afiliación
  • Wong HL; Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Hu M; Acumen, Burlingame, CA, USA.
  • Zhou CK; Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Lloyd PC; Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Amend KL; Optum Epidemiology, Boston, MA, USA.
  • Beachler DC; HealthCore, Wilmington, DE, USA.
  • Secora A; IQVIA, Falls Church, VA, USA.
  • McMahill-Walraven CN; CVS Health, Blue Bell, PA, USA.
  • Lu Y; Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Wu Y; Acumen, Burlingame, CA, USA.
  • Ogilvie RP; Optum Epidemiology, Boston, MA, USA.
  • Reich C; IQVIA, Falls Church, VA, USA.
  • Djibo DA; CVS Health, Blue Bell, PA, USA.
  • Wan Z; Acumen, Burlingame, CA, USA.
  • Seeger JD; Optum Epidemiology, Boston, MA, USA.
  • Akhtar S; Acumen, Burlingame, CA, USA.
  • Jiao Y; Acumen, Burlingame, CA, USA.
  • Chillarige Y; Acumen, Burlingame, CA, USA.
  • Do R; Acumen, Burlingame, CA, USA.
  • Hornberger J; Acumen, Burlingame, CA, USA.
  • Obidi J; Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Forshee R; Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Shoaibi A; Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Anderson SA; Office of Biostatistics and Pharmacovigilance, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: steven.anderson@fda.hhs.gov.
Lancet ; 399(10342): 2191-2199, 2022 06 11.
Article en En | MEDLINE | ID: mdl-35691322
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pericarditis / COVID-19 / Vacuna BNT162 / Vacuna nCoV-2019 mRNA-1273 / Miocarditis Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Male Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pericarditis / COVID-19 / Vacuna BNT162 / Vacuna nCoV-2019 mRNA-1273 / Miocarditis Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Humans / Male Idioma: En Revista: Lancet Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos